4-119239866-CA-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001371395.1(USP53):βc.108delβ(p.Gly37AspfsTer27) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,608,746 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000086 ( 0 hom., cov: 32)
Exomes π: 0.0000027 ( 0 hom. )
Consequence
USP53
NM_001371395.1 frameshift
NM_001371395.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.351
Genes affected
USP53 (HGNC:29255): (ubiquitin specific peptidase 53) Predicted to enable thiol-dependent deubiquitinase. Predicted to be involved in response to auditory stimulus and sensory perception of sound. Predicted to act upstream of or within action potential and neuron apoptotic process. Predicted to be located in bicellular tight junction. Predicted to be active in cell-cell junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-119239866-CA-C is Pathogenic according to our data. Variant chr4-119239866-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 2054558.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP53 | NM_001371395.1 | c.108del | p.Gly37AspfsTer27 | frameshift_variant | 5/19 | ENST00000692078.1 | NP_001358324.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP53 | ENST00000692078.1 | c.108del | p.Gly37AspfsTer27 | frameshift_variant | 5/19 | NM_001371395.1 | ENSP00000509606 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 151968Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
151968
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 246302Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133672
GnomAD3 exomes
AF:
AC:
3
AN:
246302
Hom.:
AF XY:
AC XY:
1
AN XY:
133672
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1456778Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 2AN XY: 724578
GnomAD4 exome
AF:
AC:
4
AN:
1456778
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
724578
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000855 AC: 13AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74232
GnomAD4 genome
AF:
AC:
13
AN:
151968
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74232
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with USP53-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Gly37Aspfs*27) in the USP53 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USP53 are known to be pathogenic (PMID: 32124521, 32759993). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at